VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings The acquisition is expected to close fairly quickly and without any initial shareholder dilution HOUSTON, TX / ACCESS Newswire / July 30, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital hea

Proposed acquisition, valued at $42 million, could add over $35 million in annualized revenue and more than $7 million in earnings HOUSTON, TX / ACCESS Newswire / July 29, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets.

HOUSTON, TX / ACCESS Newswire / July 28, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value. The Board believes VSee has reached an important inflection point. Over the past year, the Company has strengthened i

The recent pullback in VSee Health (NASDAQ: VSEE) has caught the attention of traders looking for high-growth healthcare technology companies. While short-term price volatility can create uncertainty, long-term investors often view these periods as opportunities to accumulate shares at more attractive valuations. Why Investors Are Watching VSEE VSee Health continues to execute on its strategy of expanding AI-powered telehealth and digital healthcare solutions. The company ser

HOUSTON, TX / ACCESS Newswire / July 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility needed to execute its growth strategy. Our Board of Directors has approved a proposed maximum of an 80-for-1 reverse stock split, subject to the completion of all applicable regul

The partnership will launch CBDL into the peptide sector, which is worth approximately $140–$165 billion in 2026. CBDL will start an initial lineup of four peptide products, representing a significant expansion of the Company's wellness platform and its commitment to delivering high-quality, science-driven products. SCOTTSDALE, AZ / July 21, 2026 / CBD Life Sciences Inc. (OTC PINK: CBDL), an emerging leader in the health and wellness industry, is pleased to announce its strat

NASDAQ: VSEE Expands Its Hospital Network to 58 Locations and Targets a $20 Million Revenue Run Rate VSee Health, Inc. (NASDAQ: VSEE) is gaining attention as the healthcare technology company sharpens its focus on enterprise telehealth, hospital operations and artificial intelligence. The company recently outlined a strategy to evolve beyond traditional telehealth services and become a broader technology infrastructure provider for hospitals. Management believes that integrat

VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation HOUSTON, TX / ACCESS Newswire / July 14, 2026 / VSee Health, Inc. (Nasdaq:VSEE) ("VSee" or the "Company"), a leading provider of enterprise telehealth solutions for hospitals and health systems, today shared its strategic initiatives and perspective on the role of artificial intelligence in healthcare and why enterprise telehealth platforms are well positioned to serve as the infrastructu

Intelligent Bio Solutions Inc. | Nasdaq: INBS Market update: July 14, 2026 Intelligent Bio Solutions Inc. is entering a potentially important period as the medical-technology company advances multiple clinical studies supporting its planned FDA 510(k) submission while continuing to grow commercial sales outside the United States. INBS develops a portable fingerprint-based drug screening system that analyzes fingerprint sweat. Sample collection takes seconds, with results avai

HOUSTON, TX / ACCESS Newswire / July 9, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an update on the Company's strategic transformation and outlook. Dear Fellow Shareholders, Over the past two years, VSee Health has undergone a significant transformation. Our objective h

Generated six-month revenue growth equivalent to an annualized rate of over 4,000%, capitalizing on accelerating demand in the CBD and Mushroom Supplement Markets, forecasted to reach a combined $45 billion by 2028. SCOTTSDALE, AZ / June 30, 2026 / CBD Life Sciences Inc. (OTC PINK:CBDL), an emerging leader in the natural health and wellness industry, is pleased to announce a 1,000% increase in revenue from January through June 2026, marking a record-breaking milestone for the

Agreement supports potential commercial readiness for Bria-IMT using Uneedle’s proprietary microneedle technology for intradermal administration Technology is currently used in BriaCell’s pivotal Phase 3 study and is designed to support faster, more convenient administration while enhancing the patient and provider experience Bria-IMT is currently being evaluated in BriaCell’s ongoing pivotal Phase 3 study in advanced metastatic breast cancer PHILADELPHIA and VANCOUVER, Brit

Key Driver for its Enterprise Telehealth Revenue Acceleration HOUSTON, June 25, 2026 (Newswire.com) - VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million. This g

Company Overview Stewards Inc., formerly FAVO Capital, Inc., is a diversified financial platform focused on three complementary business lines: private credit, income-producing real assets, and technologyenabled financial infrastructure. In November 2025, the Company rebranded as Stewards Inc. to reflect its broader long-term strategy and the expansion of its business beyond specialty finance. Since the rebrand, the Company has continued to execute on its strategy of building

Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025 HOUSTON, TX / ACCESS Newswire / June 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026. Pro-forma financials from enhanced focus on iDoc telehealth platform and enterpr

Dyadic International, Inc. (NASDAQ: DYAI), doing business as Dyadic Applied BioSolutions, is gaining attention as a small-cap biotechnology company focused on scalable microbial protein production platforms for life sciences, food and nutrition, industrial biotechnology, and biopharmaceutical applications. DYAI’s latest catalyst comes from its collaboration with researchers at Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses, incl

AUSTIN, Texas--(BUSINESS WIRE)--DBGI Corp. (NASDAQ:DBGI) a publicly traded company specializing in eCommerce and fashion today announced that its CEO, Hil Davis, purchased an additional $700,000 shares in the open market this week. DBGI CEO Hil Davis Buys an Additional $700,000 Worth of Stock on the Open Market Demonstrating Once Again His Short and Long-Term Confidence. Share The purchases, which occurred June 10, 2026, demonstrate Davis’s strong alignment with shareholders

HOUSTON, TX / ACCESS Newswire / June 11, 2026 / VSee Health, Inc. (NASDAQ:VSEE) today announced the completion of a transformative strategic transaction that separates the Company from its former laboratory subsidiary, VSee Lab, eliminates a significant block of outstanding shares, and positions VSee Health to focus exclusively on its core telehealth and digital health platform businesses. Under a Stock Purchase Agreement dated May 31, 2026, VSee Health sold 100% of VSee Lab,

The Awareness Group Inc. (OTC: TAAG) is moving onto the radar as a renewable-energy and solar-financing company focused on expanding access to residential and commercial solar solutions through its TAG GRID platform. TAAG’s latest catalyst centers on the launch of its No-FICO Solar Plus Battery Power Purchase Agreement program across seven priority markets: California, Puerto Rico, the U.S. Virgin Islands, Massachusetts, Connecticut, New Jersey, and New York. This is a key de

CEL-SCI Corporation, trading under ticker $CVM on the NYSE American, is moving back onto the high-alert biotech watchlist as the company continues advancing its lead cancer immunotherapy candidate, Multikine, toward a confirmatory registration study in head and neck cancer. Multikine is CEL-SCI’s lead investigational immunotherapy and is being developed as a potential first-line neoadjuvant therapy for patients with advanced primary squamous cell carcinoma of the head and nec